Effects of pregnancy on various pathways of human antiepileptic drug metabolism

被引:8
作者
Bernus, I [1 ]
Hooper, WD [1 ]
Dickinson, RG [1 ]
Eadie, MJ [1 ]
机构
[1] UNIV QUEENSLAND,ROYAL BRISBANE HOSP,DEPT MED,DRUG METAB & NEUROPHARMACOL LAB,BRISBANE,QLD 4029,AUSTRALIA
关键词
phenytoin; carbamazepine; pregnancy; microsomal oxidation; glucuronidation;
D O I
10.1097/00002826-199702000-00002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ratios of phenytoin and carbamazepine doses to steady-state plasma concentrations of the drugs (apparent clearances) increase in pregnant women. Mean phenytoin clearance to urinary unconjugated p-hydroxyphenytoin increased from 0.28 +/- SD 0.18 to 0.74 +/- SD 0.37 L/day in 13 pregnant women; mean clearance to p-hydroxyphenytoin glucuronide increased proportionately less (15.25 +/- SD 5.43 to 31.94 +/- SD 16.30 L/day), the proportion of the metabolite that was conjugated falling from 98.4 +/- SD 0.72% to 97.65 +/- SD 0.67%. Mean clearances to urinary phenytoin and phenytoin-dihydrodiol did not increase. In 10 epileptic women, mean clearances of carbamazepine to urinary (a) carbamazepine-10,11-epoxide (1.66 +/- SD 1.2 to 3.70 +/- SD 2.09 L/day), (b) unconjugated carbamazepine-10,11-trans-diol (33.93 +/- SD 10.21 to 47.01 +/- SD 19.58 L/day), (c) unconjugated carbamazepine-acridan (0.24 +/- SD 0.12 to 0.47 +/- SD 0.34 L/day), and (d) unconjugated 2-hydroxy-carbamazepine (0.08 +/- SD 0.09 to 0.66 +/- SD 1.14 L/day) all increased during pregnancy. Mean clearance to unconjugated 3-hydroxy-carbamazepine decreased (0.53 +/- SD 0.25 to 0.18 +/- SD 0.23 L/day), In contrast, mean clearances of carbamazepine to the glucuronides of its first stage metabolites (carbamazepine-diol, 2- and 3-hydroxy-carbamazepine and carbamazepine-acridain, respectively) did not increase in pregnancy. The conversion of carbamazepine to carbamazepine-epoxide increased proportionately more than the conversion of carbamazepine-epoxide to carbamazepine-diol. Pregnancy was thus associated with increased microsomal oxidations of phenytoin and carbamazepine, without proportionate increases in the subsequent hydrolysis of carbamazepine-10,11-epoxide and in the O-glucuronidations of the earlier stage metabolites.
引用
收藏
页码:13 / 21
页数:9
相关论文
共 12 条
[1]   ENZYME-INDUCTION BY DRUGS AND TOXINS [J].
BATT, AM ;
SIEST, G ;
MAGDALOU, J ;
GALTEAU, MM .
CLINICA CHIMICA ACTA, 1992, 209 (1-2) :109-121
[2]  
BERNUS I, 1995, EPILEPSY RES, V21, pP65
[3]  
BROWNE TR, 1989, ANTIEPILEPTIC DRUGS, P197
[4]  
DAM M, 1976, EPILEPTOLOGY, P179
[5]   THE EFFECT OF PREGNANCY IN HUMANS ON THE PHARMACOKINETICS OF STABLE ISOTOPE LABELED PHENYTOIN [J].
DICKINSON, RG ;
HOOPER, WD ;
WOOD, B ;
LANDER, CM ;
EADIE, MJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (01) :17-27
[6]   PHENYTOIN METABOLISM DURING PREGNANCY [J].
EADIE, MJ ;
MCKINNON, GE ;
DICKINSON, RG ;
HOOPER, WD ;
LANDER, CM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (04) :389-392
[7]  
Faigle JW, 1989, ANTIEPILEPTIC DRUGS, P491
[8]   HUMAN LIVER CARBAMAZEPINE METABOLISM - ROLE OF CYP3A4 AND CYP2C8 IN 10,11-EPOXIDE FORMATION [J].
KERR, BM ;
THUMMEL, KE ;
WURDEN, CJ ;
KLEIN, SM ;
KROETZ, DL ;
GONZALEZ, FJ ;
LEVY, RH .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (11) :1969-1979
[9]  
KOUCHENOUR NK, 1980, OBSTET GYNECOL, V56, P577
[10]   BIOAVAILABILITY AND PHARMACOKINETICS OF PHENYTOIN DURING PREGNANCY [J].
LANDER, CM ;
SMITH, MT ;
CHALK, JB ;
DEWYTT, C ;
SYMONIW, P ;
LIVINGSTONE, I ;
EADIE, MJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (01) :105-110